表紙
市場調查報告書
商品編碼
1029020

結膜炎治療藥的全球市場(2021年∼2025年)

Global Conjunctivitis Therapeutics Market 2021-2025

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

結膜炎治療藥的市場規模在2021年∼2025年的預測期間內,預計將以3%以上的年複合成長率推移,並成長到6億2,271萬美元。

該市場成長的主要因素有治療藥的引進率增加,以及過敏的普及及伴隨的風險增加。

本報告提供全球結膜炎治療藥市場調查,提供市場概要,市場規模和預測,趨勢,成長要素及課題,客戶形勢,類型·各地區的分析,再加上業者情勢及供應商分析等資訊。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2020年
  • 市場預測:從2020年∼2025年的預測

波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

各類型的市場區隔

  • 市場區隔
  • 各類型比較
  • 過敏性結膜炎:市場規模與預測(2020年∼2025年)
  • 細菌性結膜炎:市場規模與預測(2020年∼2025年)
  • 病毒性結膜炎:市場規模與預測(2020年∼2025年)
  • 各類型的市場機會

客戶形勢

  • 客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2020年∼2025年)
  • 歐洲:市場規模與預測(2020年∼2025年)
  • 亞洲:市場規模與預測(2020年∼2025年)
  • 其他地區:市場規模與預測(2020年∼2025年)
  • 主要國家
  • 各地區形勢市場機會
  • 市場成長促進因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況
  • 概要

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • AbbVie Inc.
  • Akorn Inc.
  • Bausch Health Companies Inc.
  • Merck and Co. Inc.
  • NovaBay Pharmaceuticals Inc.
  • Novartis AG
  • Pfizer Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

附錄

目錄
Product Code: IRTNTR70759

Technavio has been monitoring the conjunctivitis therapeutics market and it is poised to grow by $ 622.71 mn during 2021-2025, progressing at a CAGR of over 3% during the forecast period. Our report on the conjunctivitis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in the adoption rate of therapeutics and increasing prevalence of allergies and their associated risks. In addition, increase in the adoption rate of therapeutics is anticipated to boost the growth of the market as well.

The conjunctivitis therapeutics market analysis includes the type segment and geographic landscape.

Technavio's conjunctivitis therapeutics market is segmented as below:

By Type

  • Allergic conjunctivitis
  • Bacterial conjunctivitis
  • Viral conjunctivitis

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the advances in treatment optionsas one of the prime reasons driving the conjunctivitis therapeutics market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on conjunctivitis therapeutics market covers the following areas:

  • Conjunctivitis therapeutics market sizing
  • Conjunctivitis therapeutics market forecast
  • Conjunctivitis therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading conjunctivitis therapeutics market vendors that include AbbVie Inc., Akorn Inc., Bausch Health Companies Inc., Merck and Co. Inc., NovaBay Pharmaceuticals Inc., Novartis AG, Pfizer Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the conjunctivitis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Type
    • Market segments
    • Comparison by Type
    • Allergic conjunctivitis - Market size and forecast 2020-2025
    • Bacterial conjunctivitis - Market size and forecast 2020-2025
    • Viral conjunctivitis - Market size and forecast 2020-2025
    • Market opportunity by Type
  • Customer landscape
    • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Vendor landscape
    • Landscape disruption
    • Overview
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • AbbVie Inc.
    • Akorn Inc.
    • Bausch Health Companies Inc.
    • Merck and Co. Inc.
    • NovaBay Pharmaceuticals Inc.
    • Novartis AG
    • Pfizer Inc.
    • Santen Pharmaceutical Co. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Type - Market share 2020-2025 (%)
  • 22: Comparison by Type
  • 23: Allergic conjunctivitis - Market size and forecast 2020-2025 ($ million)
  • 24: Allergic conjunctivitis - Year-over-year growth 2020-2025 (%)
  • 25: Bacterial conjunctivitis - Market size and forecast 2020-2025 ($ million)
  • 26: Bacterial conjunctivitis - Year-over-year growth 2020-2025 (%)
  • 27: Viral conjunctivitis - Market size and forecast 2020-2025 ($ million)
  • 28: Viral conjunctivitis - Year-over-year growth 2020-2025 (%)
  • 29: Market opportunity by Type
  • 30: Customer landscape
  • 31: Market share By Geographical Landscape 2020-2025 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2020-2025 ($ million)
  • 34: North America - Year-over-year growth 2020-2025 (%)
  • 35: Europe - Market size and forecast 2020-2025 ($ million)
  • 36: Europe - Year-over-year growth 2020-2025 (%)
  • 37: Asia - Market size and forecast 2020-2025 ($ million)
  • 38: Asia - Year-over-year growth 2020-2025 (%)
  • 39: ROW - Market size and forecast 2020-2025 ($ million)
  • 40: ROW - Year-over-year growth 2020-2025 (%)
  • 41: Key leading countries
  • 42: Market opportunity By Geographical Landscape ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: AbbVie Inc. - Overview
  • 50: AbbVie Inc. - Product and service
  • 51: AbbVie Inc. - Key offerings
  • 52: AbbVie Inc. - Key customers
  • 53: AbbVie Inc. - Segment focus
  • 54: Akorn Inc. - Overview
  • 55: Akorn Inc. - Product and service
  • 56: Akorn Inc. - Key offerings
  • 57: Akorn Inc. - Key customers
  • 58: Akorn Inc. - Segment focus
  • 59: Bausch Health Companies Inc. - Overview
  • 60: Bausch Health Companies Inc. - Business segments
  • 61: Bausch Health Companies Inc. - Key offerings
  • 62: Bausch Health Companies Inc. - Key customers
  • 63: Bausch Health Companies Inc. - Segment focus
  • 64: Merck and Co. Inc. - Overview
  • 65: Merck and Co. Inc. - Business segments
  • 66: Merck and Co. Inc. - Key offerings
  • 67: Merck and Co. Inc. - Key customers
  • 68: Merck and Co. Inc. - Segment focus
  • 69: NovaBay Pharmaceuticals Inc.- Overview
  • 70: NovaBay Pharmaceuticals Inc.- Product and service
  • 71: NovaBay Pharmaceuticals Inc.- Key offerings
  • 72: NovaBay Pharmaceuticals Inc.- Key customers
  • 73: NovaBay Pharmaceuticals Inc.- Segment focus
  • 74: Novartis AG - Overview
  • 75: Novartis AG - Business segments
  • 76: Novartis AG - Key offerings
  • 77: Novartis AG - Key customers
  • 78: Novartis AG - Segment focus
  • 79: Pfizer Inc. - Overview
  • 80: Pfizer Inc. - Business segments
  • 81: Pfizer Inc. - Key offerings
  • 82: Pfizer Inc. - Key customers
  • 83: Pfizer Inc. - Segment focus
  • 84: Santen Pharmaceutical Co. Ltd. - Overview
  • 85: Santen Pharmaceutical Co. Ltd. - Business segments
  • 86: Santen Pharmaceutical Co. Ltd. - Key offerings
  • 87: Santen Pharmaceutical Co. Ltd. - Key customers
  • 88: Santen Pharmaceutical Co. Ltd. - Segment focus
  • 89: Sun Pharmaceutical Industries Ltd. - Overview
  • 90: Sun Pharmaceutical Industries Ltd. - Business segments
  • 91: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 92: Sun Pharmaceutical Industries Ltd. - Key customers
  • 93: Sun Pharmaceutical Industries Ltd. - Segment focus
  • 94: Teva Pharmaceutical Industries Ltd. - Overview
  • 95: Teva Pharmaceutical Industries Ltd. - Business segments
  • 96: Teva Pharmaceutical Industries Ltd. - Key offerings
  • 97: Teva Pharmaceutical Industries Ltd. - Key customers
  • 98: Teva Pharmaceutical Industries Ltd. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations